HMR Program Named a No. 1 “Best Fast Weight-Loss Diet” by U.S. News & World Report
HMR Program also Named the No. 2 “Best Weight-Loss Diet” for Second Year in a Row
PR Newswire – BOSTON, Jan. 5, 2016
HMR Weight Management Services (HMR), a subsidiary of Merck, has been named a No. 1 Best Fast Weight-Loss Diet in U.S. News & World Report’s Best Diets of 2016 rankings. This is the first year U.S. News has published the Best Fast Weight-Loss Diet category. HMR also held its position as the No. 2 Best Weight-Loss Diet in the annual rankings list for the second year in a row. HMR Programs focus on helping people lose weight quickly while teaching the healthy lifestyle skills needed for long-term weight management.
“HMR programs excel at providing the jump start many people need when beginning a healthier lifestyle program,” said Carol Addy, M.D. MMSc, Chief Medical Officer at HMR. “A common misconception is that losing weight quickly is not healthy, not sustainable, and will just lead to future weight re-gain. To the contrary, numerous clinical studies demonstrate that following a lifestyle change program which promotes fast initial weight loss can result in better long-term success.” Addy added, “On the HMR Program, people can lose weight without feeling hungry. Our programs achieve fast weight loss in a livable way by encouraging people to eat more and stay satisfied, which makes it easier to stick to the program in the short-term, and over the long haul.”
Selected Weight Loss Results from Clinical Studies on the HMR Program
In a clinical study, 1,100 participants with a BMI of 40 or higher who completed at least 12 weeks of the HMR program lost an average of 66 lbs. after 26 weeks (using either the HMR Decision-Free® or Healthy Solutions® program). Participants using the Healthy Solutions® at Home program had a median weight loss of 23 lbs. over the first 12 weeks of the program. Clinically meaningful weight loss is typically defined as losing 5 percent or more of initial body weight. Healthy Solutions at Home participants using phone support maintained an average weight loss of 7.4 percent of initial body weight 18 months after starting the program.
Selected Health Outcomes from the HMR Program
It is well reported that weight loss is associated with favorable changes in medical risk factors. Below are health risk reductions and medication changes for 721 HMR patients who participated in a clinic-based program (mean duration of participation 107.6 weeks):
- Fasting Glucose (mg/dL): -9.4 percent
- Total Cholesterol / HDL ratio: -10.3 percent
- Diastolic / Systolic Blood Pressure: -7mmHg / -4 mmHg
- Triglycerides (mg/dL): -26.7 percent
- Of 126 patients taking oral diabetes medications at baseline, 40.5 percent (n=51) had discontinued these medications at follow-up.
- Of 337 patients taking blood pressure medications at baseline, 36.2 percent (n=122) had discontinued these medications at follow-up.
The U.S. News & World Report Ranking Process
During the ranking process, reporters and editors from U.S. News & World Report created in-depth profiles of 38 diets. A panel of nationally recognized experts on diet, nutrition, obesity, food psychology, diabetes and heart disease rated the diets on their effectiveness.
“The Best Diets rankings are designed to help consumers identify a diet that suits their specific weight and lifestyle needs,” said Angela Haupt, senior health & wellness editor for U.S. News & World Report. “This year we published the Best Fast Weight-Loss Diet category because we recognize dieters may have short-term weight goals and need options to accomplish that in a healthy way.”
About HMR Weight Management Services Corp. (HMR)
HMR Weight Management Services (HMR) specializes in weight loss and weight management. HMR programs, available in person or at home, offer lifestyle education, a structured diet and an emphasis on long-term weight and health management. Founded in 1983 by Lawrence T.P. Stifler, Ph.D. and headquartered in Boston, MA, HMR’s medically-based programs are available to clinics, hospitals major medical centers, and integrated delivery networks throughout the United States. For more information, visit www.hmrprogram.com and connect with us on Twitter, Facebook and YouTube Channel: HMR Program.
Today's Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co. Inc., Kenilworth, NJ, USA
This news release of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
# # #